CEO SUMMARY: When the Office of the Inspector General (OIG) at the Department of Health and Human Services (HHS) issued its latest report on Medicare spending in 2023 for clinical laboratory tests, it attracted relatively little attention from the lab industry. Maybe other issues—such as compliance with the FDA’s LDT rule—are getting more attention at […]
To access this post, you must purchase The Dark Report.